Antonio Pazzola

1.5k total citations
43 papers, 767 citations indexed

About

Antonio Pazzola is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Antonio Pazzola has authored 43 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 14 papers in Cardiology and Cardiovascular Medicine and 14 papers in Oncology. Recurrent topics in Antonio Pazzola's work include Lung Cancer Treatments and Mutations (10 papers), Renin-Angiotensin System Studies (8 papers) and Cancer Genomics and Diagnostics (6 papers). Antonio Pazzola is often cited by papers focused on Lung Cancer Treatments and Mutations (10 papers), Renin-Angiotensin System Studies (8 papers) and Cancer Genomics and Diagnostics (6 papers). Antonio Pazzola collaborates with scholars based in Italy, France and United Kingdom. Antonio Pazzola's co-authors include Anders Vikström, В. А. Горбунова, Achim Rittmeyer, Fabrice Barlési, Myung‐Ju Ahn, Arnaud Scherpereel, Harry J.M. Groen, Joachim G.J.V. Aerts, Elaine K. Wong and Pablo Ernesto Pérez and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Annals of Oncology.

In The Last Decade

Antonio Pazzola

38 papers receiving 747 citations

Peers

Antonio Pazzola
Antonio Pazzola
Citations per year, relative to Antonio Pazzola Antonio Pazzola (= 1×) peers Yasunori Shikada

Countries citing papers authored by Antonio Pazzola

Since Specialization
Citations

This map shows the geographic impact of Antonio Pazzola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Pazzola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Pazzola more than expected).

Fields of papers citing papers by Antonio Pazzola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Pazzola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Pazzola. The network helps show where Antonio Pazzola may publish in the future.

Co-authorship network of co-authors of Antonio Pazzola

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Pazzola. A scholar is included among the top collaborators of Antonio Pazzola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Pazzola. Antonio Pazzola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sanna, Valeria, Palma Fedele, Giulia Deiana, et al.. (2022). Edmonton Symptom Assessment Scale may reduce medical visits in patients undergoing chemotherapy for breast cancer. World Journal of Clinical Oncology. 13(7). 577–586. 4 indexed citations
3.
Vaira, Luigi Angelo, Andrea De Vito, Giovanna Deiana, et al.. (2021). Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study. European Archives of Oto-Rhino-Laryngology. 279(2). 811–816. 17 indexed citations
4.
Vaira, Luigi Angelo, Andrea De Vito, Giovanna Deiana, et al.. (2021). Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?. The Journal of Laryngology & Otology. 135(8). 723–728. 14 indexed citations
5.
Paliogiannis, Panagiotis, Angelo Zinellu, Arduino A. Mangoni, et al.. (2021). Prothrombin time, international normalized rate and in-hospital mortality in COVID-19. 61(2).
6.
Floris, Matteo, Daria Sanna, Paolo Castiglia, et al.. (2020). MTHFR, XRCC1 and OGG1 genetic polymorphisms in breast cancer: a case-control study in a population from North Sardinia. BMC Cancer. 20(1). 234–234. 18 indexed citations
7.
Migliorino, Maria Rita, Antonio Santo, Giampiero Romano, et al.. (2017). Economic burden of patients affected by non-small cell lung cancer (NSCLC): the LIFE study. Journal of Cancer Research and Clinical Oncology. 143(5). 783–791. 36 indexed citations
8.
Cortesi, Enrico, Federico Cappuzzo, Luca Galli, et al.. (2017). Treatment beyond progression in patients with advanced RCC participating in the expanded access programme (EAP). Annals of Oncology. 28. v316–v316. 4 indexed citations
9.
Palomba, Grazia, Antonio Cossu, Panagiotis Paliogiannis, et al.. (2016). Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma. Oncology Letters. 12(2). 1415–1421. 5 indexed citations
10.
Paliogiannis, Panagiotis, Federico Attene, Antonio Cossu, et al.. (2015). Impact of tissue type and content of neoplastic cells of samples on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma. Molecular Medicine Reports. 12(1). 187–191. 15 indexed citations
11.
Barlési, Fabrice, Arnaud Scherpereel, В. А. Горбунова, et al.. (2014). Maintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial. Annals of Oncology. 25(5). 1044–1052. 129 indexed citations
12.
Palomba, Grazia, Maria Colombino, A. Contu, et al.. (2012). Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia. Journal of Translational Medicine. 10(1). 178–178. 28 indexed citations
13.
Bracarda, Sergio, Camillo Porta, C. Boni, et al.. (2012). Could Interferon Still Play a Role in Metastatic Renal Cell Carcinoma? A Randomized Study of Two Schedules of Sorafenib Plus Interferon-Alpha 2a (RAPSODY). European Urology. 63(2). 254–261. 21 indexed citations
14.
Troffa, Chiara, Giancarlo Tonolo, Maria Grazia Melis, et al.. (1991). Effect of Angiotensin Converting Enzyme Inhibition on the Menstrual Cycle of Hypertensive Women. Journal of Cardiovascular Pharmacology. 18(3). 462–467. 4 indexed citations
15.
Troffa, Chiara, Giancarlo Tonolo, Paolo Manunta, et al.. (1991). Prorenin is present in human red blood cells. Canadian Journal of Physiology and Pharmacology. 69(9). 1394–1397.
16.
Tonolo, Giancarlo, Chiara Troffa, Antonio Pazzola, et al.. (1990). Efficacy and tolerability of a new once-daily nifedipine formulation in mild to moderate essential hypertension. Current Therapeutic Research. 47(1). 76–80. 3 indexed citations
17.
Madeddu, Paolo, Nicola Glorioso, Aldo Soro, et al.. (1990). Effect of a kinin antagonist on renal function and haemodynamics during alterations in sodium balance in conscious normotensive rats. Clinical Science. 78(2). 165–168. 9 indexed citations
18.
Madeddu, P., Chiara Troffa, Nicola Glorioso, et al.. (1989). Effect of Endothelin on Regional Hemodynamics and Renal Function in Awake Normotensive Rats. Journal of Cardiovascular Pharmacology. 14(6). 818–825. 33 indexed citations
19.
Tonolo, Giancarlo, Aldo Soro, Chiara Troffa, et al.. (1989). Correlates of atrial natriuretic factor in chronic renal failure. Journal of Hypertension. 7(6). S238–239. 3 indexed citations
20.
Tonolo, Giancarlo, M. Tree, Antonio Pazzola, & B Leckie. (1988). Similarity between active and trypsin-activated inactive renin in dog plasma by means of renin inhibition: the dog as an animal model for studies of inactive renin. Journal of Hypertension. 6(12). 975–980. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026